RQM+ – Medical Alley Association

In the Know: Healthcare News for March 7, 2022

Arden Hills’ Intricon Selling for $241 Million to Private-Equity Group RQM+ Appoints Life Science Executive Margaret Keegan as New CEO Cardiovascular Systems, Inc. Appoints Jeffery W. Chambers, M.D., as Chief Medical Officer LEAH Labs Awarded NIH Phase I SBIR Grant Saluda Medical Announces $125M Equity Financing Led by Redmile Group LLC and New Investors Fidelity […]

For the Record with Lisa Casavant, Executive Vice President, RQM+

Lisa cofounded R&Q in 2008, which was rebranded to RQM+ in 2020. As a member of the board of directors and executive leadership team, Lisa supports strategic planning and execution, and provides guidance across the company. Lisa leads the RQM+ Marketing Team, focusing on creating and executing innovative marketing strategies to profitably increase revenue and grow the brand.  […]

RQM+ MDR Clinical Evaluation Roadmap: An Interview with Jai Kutty

The introduction of MDR caused a major transformation in the medical device industry. Manufacturers continue to grapple with all elements of compliance, but clinical evaluation presents unique challenges. RQM+ is committed to helping clients navigate these challenges with former notified body leaders who understand what reviewers are looking for when evaluating clinical evidence. Introduction to Dr. […]

In The Know: Healthcare News for January 18, 2021

HistoSonics Receives Approval to Begin European #HOPE4LIVER Clinical Study Steris to Acquire Cantel Medical in $4.6B Deal Recombinetics Inc. Announces Neurofibromatosis Type 1 Research Collaboration with AstraZeneca OX2’s New Treatment for Central Nervous System Tumors Enters Phase I Clinical Trials Health, Tech Groups Aim to Create Digital Covid ‘Vaccination Passport’ Respicardia Announces Highmark Coverage for the […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER